X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-14 | XAIR | Carey Robert | Dir | P - Purchase | $0.25 | +1,000,000 | 5,553,490 | +22% | +$250,050 | ||||||
2025-02-19 | XAIR | Gaul Michael A. | COO | P - Purchase | $0.38 | +6,000 | 94,150 | +7% | +$2,294 | ||||||
| D | 2024-09-26 | XAIR | Carey Robert | Dir | P - Purchase | $0.50 | +1,476,626 | 1,476,626 | New | +$744,662 | |||||
| D | 2024-09-26 | XAIR | Lisi Steven A. | CEO, COB | P - Purchase | $0.50 | +1,476,626 | 3,249,411 | +83% | +$744,662 | |||||
2024-08-15 | XAIR | Lisi Steven A. | CEO, COB | P - Purchase | $0.37 | +50,000 | 1,772,785 | +3% | +$18,340 | ||||||
2024-08-14 | XAIR | Lucera Erick | Dir | P - Purchase | $0.40 | +39,266 | 43,608 | +904% | +$15,565 | ||||||
2024-08-14 | XAIR | Carey Robert | Dir | P - Purchase | $0.40 | +100,000 | 3,076,864 | +3% | +$39,680 | ||||||
2024-08-14 | XAIR | Lisi Steven A. | CEO, COB | P - Purchase | $0.39 | +100,000 | 1,722,785 | +6% | +$38,640 | ||||||
2023-12-28 | XAIR | Avniel Amir | Chief Business Officer | S - Sale | $2.06 | -25,000 | 685,760 | -4% | -$51,451 | ||||||
2023-12-27 | XAIR | Myers Jeff Lynn | Chief Medical Officer | S - Sale | $2.21 | -3,423 | 46,577 | -7% | -$7,579 | ||||||
2023-12-18 | XAIR | Lisi Steven A. | CEO, COB | P - Purchase | $1.63 | +77,775 | 1,536,471 | +5% | +$126,797 | ||||||
2023-12-18 | XAIR | Carey Robert | Dir | P - Purchase | $1.64 | +1,200,000 | 2,374,454 | +102% | +$1,962,000 | ||||||
2023-11-16 | XAIR | Gaul Michael A. | COO | P - Purchase | $1.77 | +10,000 | 88,150 | +13% | +$17,700 | ||||||
2023-08-28 | XAIR | Carey Robert | Dir | P - Purchase | $2.70 | +250,000 | 1,225,160 | +26% | +$673,750 | ||||||
| M | 2023-08-18 | XAIR | Carey Robert | Dir | P - Purchase | $2.75 | +88,664 | 975,160 | +10% | +$243,393 | |||||
2023-06-30 | XAIR | Gaul Michael A. | COO | P - Purchase | $4.51 | +5,000 | 78,150 | +7% | +$22,550 | ||||||
2023-03-31 | XAIR | Forbes William P | Dir | P - Purchase | $6.67 | +5,000 | 14,855 | +51% | +$33,350 | ||||||
| M | 2023-03-29 | XAIR | Carey Robert | Dir | P - Purchase | $6.38 | +20,000 | 886,496 | +2% | +$127,500 | |||||
2023-03-28 | XAIR | Lee Yoori | Dir | P - Purchase | $6.34 | +3,115 | 12,654 | +33% | +$19,749 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |